Jérémy Manry

CEA Paris-Saclay — France

Medicine · Health Sciences

27h-index8.3kcitations50works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mycobacterium research and diagnosis(17), interferon and immune responses(12), SARS-CoV-2 and COVID-19 Research(10), Tuberculosis Research and Epidemiology(8), Leprosy Research and Treatment(8)

Publications50 total

Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria
UNC Libraries·2025Open Access
A human YEATS4 variant confers resistance to TST and IGRA conversion despite Mycobacterium tuberculosis exposure
Genome Medicine·2025· 1 citedOpen Access
Transcriptome immune-regulatory differences between leprosy patients and type 1 reaction patients, before onset of symptoms
PLoS neglected tropical diseases·2024· 1 citedOpen Access
Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Genome Medicine·2024· 1 citedOpen Access
Type 1 reaction leprosy patients display distinct immune-regulatory capacity before onset of symptoms
2023· 2 citedOpen Access
A novel pediatric polycystic lung disease caused by CCR2 deficiency
2023
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Genome Medicine·2023· 76 citedOpen Access
Allele-dependent interaction of LRRK2 and NOD2 in leprosy
PLoS Pathogens·2023· 9 citedOpen Access
Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria
Cell·2023· 100 citedOpen Access
Additional file 2 of Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Figshare·2023Open Access
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
2022· 10 citedOpen Access
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
The Journal of Experimental Medicine·2022· 113 citedOpen Access
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
Science Immunology·2022· 73 citedOpen Access
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Proceedings of the National Academy of Sciences·2022· 180 citedOpen Access
Human genetic and immunological determinants of critical COVID-19 pneumonia
Nature·2022· 380 citedOpen Access
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies
2022· 24 citedOpen Access
Inborn errors of TLR3- or MDA5-dependent type I IFN immunity in children with enterovirus rhombencephalitis
The Journal of Experimental Medicine·2021· 38 citedOpen Access
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
Science Immunology·2021· 600 citedOpen Access
Early onset leprosy reveals a joint effect of <i>LRRK2</i> and <i>NOD2</i> variants
2021Open Access
Autoantibodies neutralizing type I IFNs are present in similar to 4% of uninfected individuals over 70 years old and account for similar to 20% of COVID-19 deaths
Science Immunology·2021· 1 cited
page 1 of 3Next →

Frequent Co-authors

Laurent Abel(19), Lluís Quintana‐Murci(18), Paul Bastard(17), Lazaro Lorenzo(14), Jérémie Rosain(13), Lucy Bizien(12), Filomeen Haerynck(12), Quentin Philippot(11), Yacine Tandjaoui-Lambiotte(11), Diederik van de Beek(11), Andrés A. Arias(11), Tayfun Özçelık(11), Adrian Gervais(11), Yu Zhang(10), Yoann Seeleuthner(10), Alessandro Aiuti(10), Giorgio Casari(10), Sevgi Keleş(10), Qiang Pan‐Hammarström(10), Lennart Hammarström(10)